DT&CRO CO., Ltd. (KOSDAQ:383930)

Market Cap	75.36B
Revenue	n/a
Net Income	n/a
Shares Out	12.73M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	212,561
Average Volume	254,427
Open	6,160.00
Previous Close	6,190.00
Day's Range	5,920.00 - 6,220.00
52-Week Range	5,260.00 - 11,500.00
Beta	3.97
RSI	38.09
Earnings Date	n/a

About DT&CRO CO.

DT&CRO CO., Ltd. operates as a full-service CRO provider in South Korea. It conducts a series of consigned studies ranging from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional foods, cosmetics, and medical devices to analysis, bioactivity, clinical trials, and licensing consulting. DT&CRO CO., Ltd. was founded in 2017 and is based in Yongin, South Korea.

• Industry: Commercial Physical and Biological Research
• Founded: 2017
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 383930